Healthcare / Medical Care FacilitiesThailand
$1.17
-0.01 (-0.85%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 18%
FCF escenarios
weak_data · normalized FCF $-24.9M · quality 46.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
56/100
C
Piotroski
6/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$351M
P/E
8.4x
↓EV/EBITDA
3.7x
↓ROE
8.2%
↑Gross Margin
18.8%
↓Debt/Equity
0.16
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+23.1%
FCF CAGR
—
FCF margin
-3.5%
FCF / Net income
-0.56x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $703.8M · net income $44.4M · FCF $-24.9M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $703.8M | $703.8M | $596.8M | $456.1M | $377.6M |
| Net Income | $44.4M | $44.4M | $19.2M | $14.2M | $21.2M |
| EBITDA | $107.9M | $107.9M | $67.8M | $48.5M | $51.5M |
| EPS | 0.15 | 0.15 | 0.06 | 0.05 | 0.09 |
| Gross Margin | 18.8% | 18.8% | 16.1% | 18.1% | 19.0% |
| Operating Margin | 8.7% | 8.7% | 4.4% | 4.4% | 7.6% |
| Net Margin | 6.3% | 6.3% | 3.2% | 3.1% | 5.6% |
| Balance Sheet | |||||
| Debt/Equity | 0.16 | 0.16 | 0.12 | 0.11 | 0.19 |
| Current Ratio | 2.11 | 2.11 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-24.9M | $-24.9M | $-4.2M | $-144.3M | $-45.3M |
| Returns | |||||
| ROE | 8.2% | 8.2% | 3.8% | 2.9% | 4.4% |
| Valuation | |||||
| P/E | 8.36 | 8.36 | 30.00 | 56.00 | 40.89 |
| EV/EBITDA | 3.73 | 3.73 | 7.89 | 17.79 | 12.74 |
| P/B | 0.65 | 0.65 | 1.07 | 1.71 | 1.72 |
| Growth & Yield | |||||
| Revenue Growth | 17.9% | 17.9% | 30.8% | 20.8% | — |
| EPS Growth | 150.0% | 150.0% | 20.0% | -44.4% | — |
| Dividend Yield | 1.1% | 1.1% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
-11.5%
EPS terminal req.
$0.10
Spread vs growth
161.5%
5Y implied EPS CAGR
-3.5%
EPS terminal req.
$0.13
Spread vs growth
153.5%
10Y implied EPS CAGR
3.0%
EPS terminal req.
$0.20
Spread vs growth
147.0%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-27.6%
Start / end P/E
27.3x → 7.8x
EPS bridge
0.06 → 0.15
Residual
-107.2%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.